NIP
TMDX icon

Nicholas Investment Partners’s Transmedics TMDX Stock Holding History

Nicholas Investment Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-87,390
Closed -$13.7M – 246
2024
Q3 		$13.7M Buy
87,390
+1,999
+2% +$308K 1.26% 10
2024
Q2 		$12.9M Buy
85,391
+26,470
+45% +$3.17M 1.33% 15
2024
Q1 		$4.36M Buy
58,921
+423
+0.7% +$34.9K 0.45% 86
2023
Q4 		$4.62M Sell
58,498
-355,216
-86% -$21.4M 0.54% 71
2023
Q3 		$22.7M Buy
413,714
+46,083
+13% +$3.32M 1.69% 18
2023
Q2 		$30.9M Buy
367,631
+223
+0.1% +$17.1K 2.11% 11
2023
Q1 		$27.8M Buy
367,408
+77,704
+27% +$5.37M 2.11% 10
2022
Q4 		$17.9M Buy
289,704
+12,079
+4% +$642K 1.57% 14
2022
Q3 		$11.6M Buy
+277,625
New +$12.1M 1.07% 34

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nicholas Investment Partners's TMDX Position: Q4 2024 in Review

Nicholas Investment Partners sold out of Transmedics (TMDX) in Q4 2024, closing a stake of 87,390 shares — an estimated $13.7M sold.

Nicholas Investment Partners first reported a position in TMDX in Q3 2022 and held it in 9 quarters. The position peaked at $30.9M in Q2 2023. 315 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

  • Nicholas Investment Partners reported no remaining Transmedics position as of Q4 2024 after selling out during the quarter.
  • Nicholas Investment Partners sold 87,390 Transmedics shares in Q4 2024, an estimated $13.7M.
  • Nicholas Investment Partners first reported a position in Transmedics in Q3 2022 and held it in 9 quarters.
  • Nicholas Investment Partners's Transmedics position peaked at $30.9M in Q2 2023.
  • 315 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on Nicholas Investment Partners's 13F filing for Q4 2024, filed 14 Feb 2025.